This is exacerbated by NRF2 pathway suppression due to hyperinsulinemia-induced KEAP1 stabilization, which downregulates GPX4 and depletes GSH, rendering HCC cells vulnerable to sorafenib-induced ferroptosis. The gene discussed is NFE2L2; the disease is hyperinsulinism.